The first large real-world study of how vaccines hold up against Omicron found that two shots of Pfizer and BioNTech’s Covid-19 vaccine lowered the risk of hospital admission by 70% for patients infected with the highly mutated variant on.wsj.com
@telegraph.co.uk3 years ago
Omicron is less severe than Covid delta variant and two vaccine jabs give good protection, study suggests
@abc.net.au4 years ago
South African COVID variant can 'break through' Pfizer vaccine, Israeli study says
@theguardian.com4 years ago
WHO's Covid warnings were not heeded. Now the world has a new chance to beat the virus